These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36178566)

  • 1. Side Effects of COVID-19 Vaccines in Patients with Inflammatory Bowel Disease in Japan.
    Miyazaki H; Watanabe D; Ito Y; Okamoto N; Tokunaga E; Ku Y; Ooi M; Hoshi N; Kodama Y
    Dig Dis Sci; 2023 Feb; 68(2):564-570. PubMed ID: 36178566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Coronavirus disease - 19 vaccination related side effects in patients with ulcerative colitis and Crohn's disease in Japan.
    Miyazaki H; Watanabe D; Ito Y; Ikeda S; Okamoto N; Tokunaga E; Ku Y; Ooi M; Hoshi N; Kodama Y
    Indian J Gastroenterol; 2023 Oct; 42(5):701-707. PubMed ID: 37505394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
    Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
    BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
    Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
    Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From trial to practice: incidence and severity of COVID-19 vaccine side effects in a medically at-risk and vaccine-hesitant community.
    Joyce MC; Mountjoy NJ; Johnson JA; Newman JT; Bandy DL; Atalla NA; Singh A; McElroy D
    BMC Public Health; 2022 Dec; 22(1):2351. PubMed ID: 36517842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
    Weaver KN; Zhang X; Dai X; Watkins R; Adler J; Dubinsky MC; Kastl A; Bousvaros A; Strople JA; Cross RK; Higgins PDR; Ungaro RC; Bewtra M; Bellaguarda E; Farraye FA; Boccieri ME; Firestine A; Kappelman MD; Long MD
    Inflamm Bowel Dis; 2022 Oct; 28(10):1497-1505. PubMed ID: 34871388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study.
    Mujukian A; Kumar R; Li D; Debbas P; Botwin GJ; Cheng S; Ebinger J; Braun J; McGovern D; Melmed GY;
    Inflamm Bowel Dis; 2024 Apr; 30(4):602-616. PubMed ID: 37556401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study.
    Shehab M; Alrashed F; Alfadhli A
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccine Hesitancy among Patients with Inflammatory Bowel Disease Receiving Biologic Therapies in Kuwait: A Cross-Sectional Study.
    Shehab M; Zurba Y; Al Abdulsalam A; Alfadhli A; Elouali S
    Vaccines (Basel); 2021 Dec; 10(1):. PubMed ID: 35062716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan.
    Kitagawa H; Kaiki Y; Sugiyama A; Nagashima S; Kurisu A; Nomura T; Omori K; Akita T; Shigemoto N; Tanaka J; Ohge H
    J Infect Chemother; 2022 Apr; 28(4):576-581. PubMed ID: 35058126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptance of COVID-19 Vaccines among Patients with Inflammatory Bowel Disease in Japan.
    Nishida Y; Hosomi S; Kobayashi Y; Nakata R; Ominami M; Nadatani Y; Fukunaga S; Otani K; Tanaka F; Nagami Y; Taira K; Kamata N; Fujiwara Y
    Healthcare (Basel); 2021 Dec; 10(1):. PubMed ID: 35052170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Sex and Age on mRNA COVID-19 Vaccine-Related Side Effects in Japan.
    Mori M; Yokoyama A; Shichida A; Sasuga K; Maekawa T; Moriyama T
    Microbiol Spectr; 2022 Dec; 10(6):e0130922. PubMed ID: 36314943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 2 vs 3 Doses of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity Matched Analysis.
    Desai A; Deepak P; Cross RK; Murone J; Farraye FA; Ungaro RC; Kochhar GS
    Inflamm Bowel Dis; 2023 Oct; 29(10):1563-1571. PubMed ID: 36576102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with IBD have a more cautious attitude towards COVID-19 vaccination.
    Hu S; Liu J; Li S; Wu Q; Wang X; Xu D; Chen Y
    Front Immunol; 2022; 13():1077308. PubMed ID: 36741375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of post-vaccine side effects among COVID-19 immunized community of Southern Pakistan.
    Qureshi A; Syed Sulaiman SA; Rehman W; Mehmood A; Idrees S; Kumar N
    PLoS One; 2023; 18(5):e0285736. PubMed ID: 37220099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological response to vaccines against SARS-CoV-2 in patients with inflammatory bowel disease.
    Algaba A; Romero S; Granja A; Garza D; Aller M; Barrero S; Guerra I; Gil M; Pizarro N; Ruiz P; Prieto S; Hernández B; Pou A; Bermejo F
    Gastroenterol Hepatol; 2023 Jan; 46(1):48-53. PubMed ID: 35605819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
    Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
    PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of age, sex and medical history on adverse reactions to the first and second dose of BNT162b2 mRNA COVID-19 vaccine in Japan: a cross-sectional study.
    Urakawa R; Isomura ET; Matsunaga K; Kubota K; Ike M
    BMC Infect Dis; 2022 Feb; 22(1):179. PubMed ID: 35197017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.